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Background: Patients admitted into the intensive care unit (ICU) usually have
impaired immunity and are therefore at high risk of acquiring hospital associated
infections. Infections caused by multidrug resistant organisms now constitute a
major problem, limiting the choice of  antimicrobial therapy.
Objectives: This study was aimed at determining the antimicrobial resistance pattern
of pathogens causing ICU infections in University College Hospital (UCH), Ibadan,
Nigeria. The aetiological agents, prevalence and types ICU infections were also
determined.
Methods: One year hospital associated infections surveillance was conducted in the
ICU of UCH, Ibadan. Blood, urine, tracheal aspirate and wound biopsies specimens
were collected under strict asepsis and sent to the Medical Microbiology laboratory
of  the same institution for immediate processing. All pathogens were isolated and
identified by standard microbiological methods. Disk diffusion antibiotic
susceptibility testing was performed and interpreted according to Clinical and
Laboratory Standards Institute (CLSI) guidelines.
Results: The overall prevalence of ICU infections was 30.9% out of which 12.9%
were bloodstream infections, 31.5% urinary tract infections, 38.9% pneumonia, and
16.7% skin and soft tissue infections. Klebsiella species and Escherichia coli were
the predominant pathogens. Multidrug resistant organisms constituted 59.3% of
the pathogens, MDR Klebsiella spp and MDR E. coli were 70.8% and 71.4%
respectively. Resistance to Cefuroxime was the highest (92.9%) while Meropenem
had the least resistance (21.4%).
Conclusion: There is a high prevalence of multidrug resistant bacteria causing ICU
infections. Application of more stringent infection control procedures and institution
of functional antimicrobial stewardship are recommended to combat this problem.
Keywords: Healthcare associated infections, Infection control, Antibiotic resistance, Intensive care unit.
INTRODUCTION
Nosocomial infections, which are now known as
hospital-acquired or healthcare-associated infections
rank high among important public health problems
globally, and developing countries in particular.1,2
Patients who are admitted into the intensive care unit
(ICU) usually have impaired immunity either due to
their underlying disease conditions or exposure to
invasive procedures which adversely affect their
immune mechanisms. They are therefore at high risk
of  acquiring nosocomial infections. In addition, they
are susceptible to secondary infections such as
candidiasis and pseudomembranous colitis arising from
destruction of protective microbiota by administration
of  broad spectrum antimicrobials.3,4,5
Hospital-associated infection, a serious problem for
patients admitted into the ICU, is associated with
appreciable cost of  care, length of  hospital stay,
morbidity and mortality.6,7 It has been documented
that acquiring ICU infection is an independent factor
associated with hospital mortality and that ICU patients
with infections have two times the death rate of those
not infected.7,8 About 40% of the total expenditure in
the ICU is related to infections.7 ICU infections and
indeed all healthcare associated infections have also been
noted to be much higher in low and middle income
countries compared with high income countries.9
Bloodstream infections, pneumonia, surgical site
infections, and other nosocomial infections affect ICU
patients more than patients in other areas of the health
care setting.10 Globally, 12 - 49% ICU infection rate
has been reported with a median time to infection
being 4 days and most patients develop an infection
within 6 days of admission.11,12,13
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Nosocomial infections are often due to resistant
organisms which exhibit intrinsic and/or acquired
resistance to antimicrobial agents.14 Multidrug resistant
(MDR) organisms are those with acquired non-
susceptibility to one or more agents in at least three
antimicrobial categories.15 This antimicrobial resistance
is on the rise and multidrug drug resistant organisms
are now widespread. However, therapeutic options
for these resistant infections are limited thus threatening
optimal antibiotic coverage of patients with such
infections.16,17 In addition to therapeutic challenges,
multidrug resistant pathogens also have a high potential
for acquiring additional resistance and being widely
disseminated within the hospital, posing a higher threat
to the control of infection.18 Antibiotic resistance has
been reported to be higher among those on prolonged
hospitalization which is a frequent finding in ICU
patients.19 There are also reports that patients with
MDR pathogens have a higher ICU-mortality than
those with non-MDR.20
One study reported an overall almost 4-fold increase
in MDR gram negative bacteria over their study period
with the highest individual increases of 73-fold seen in
Enterococci and 14.6-fold in Klebsiella pneumoniae.21 The
resistance rates for Gram negative bacteria was 36%
while for Gram positive cocci was 51.7%.21
The causes of antibiotic resistance and MDR organisms
though multifactorial are related to selective pressure
that result from inappropriate antibiotic use. 17
Although a general increase in the number of resistant
microorganisms is being reported worldwide, there is
considerable variation in the specific patterns and rates
of MDR across the countries and geographical
regions.17,21 This reiterates the need for locally relevant
data which can be used to predict the resistance type
and also guide choice of antibiotics when infections
occur.17 The development of  proper strategies for
combating multidrug resistant pathogens require
adequate knowledge of the prevalent pathogens, types
of infections and the antimicrobial susceptibility
pattern.22 This study was conducted to determine the
resistance pattern of  ICU pathogens to antibiotics. We
also determined the prevalence of  ICU infections,
types and pathogens associated with such infections.
MATERIALS AND METHODS
All patients admitted into the ICU of the University
College Hospital (UCH), Ibadan, from January 1 to
December 31, 2014 were included in the study.
University College Hospital, Ibadan, is an 850 bed
tertiary care facility in Southwestern Nigeria with a
combined medical and surgical ICU. Socio-
demographic and clinical data related to these patients
were retrieved from the infection control surveillance
records using a structured proforma. Ethical approval
was obtained from the UI/UCH Ethics Committee.
All patients who developed infections after at least 48
hours of hospitalization were considered to have ICU
acquired infections. Appropriate specimens were
collected under strict asepsis and sent to the Medical
Microbiology laboratory of  UCH, Ibadan for
immediate processing. The specimens included blood,
urine, wound swabs, biopsies and tracheal aspirates.
All pathogens were isolated and identified by standard
microbiological methods for aerobic bacteria.23
Antibiotic susceptibility testing was performed using
the disk diffusion technique with antibiotics discs
containing Augmentin 20+10µg, Cefuroxime 30µg,
Ceftazidime 30µg, Ceftriaxone 30µg, Gentamycin
30µg, Amikacin 30µg, Ciprofloxacin 5µg, Pefloxacin
5µg, Levofloxacin 5µg and Meropenem 10µg. It was
interpreted according to Clinical and Laboratory
Standards Institute (CLSI) guidelines.24
Data analysis was done using the Statistical Package
for the Social Sciences (SPSS), version 22 software.
Data was categorized into appropriate groups and
summarized using means, range and proportions and
then presented using frequency tables. Differences in
proportions were compared using the one sample t-
test. Level of significance was set at p<0.05
RESULTS
Prevalence of ICU infections
A total of 152 patients were admitted into the ICU
during the study period. Of these, 47 developed

















































Table 1: Distribution of  age groups and sex of
patients
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these patients had more than one infection therefore
there was a total of  54 infections.
Demographic characteristics of patients with
infections
The age range of patients was 8 - 85 years with a mean
age of  42 (±19) years. Table 1 shows the distribution
by age group. The highest number of  patients was in
the 20-29 age group followed by 40-49 years age group.
There was no significant difference in the proportion
of the young (<40 years) and the older age group
p=0.381. Among the 47 patients with ICU infections,
27 (57.4%) were males while 20 (42.6%) were females)
p=0.381.
Types of ICU infections
Table 2 shows the distribution of  the types of
infections acquired in the ICU. The most common
site was the lungs, accounting for about 39% of
infections, followed by the urinary tract. Blood stream
infections had the lowest prevalence of 12.9%.
Organisms isolated and prevalence of multidrug
resistant pathogens
The distribution of  isolates is as shown in Table 3. The
frequency of Gram-negative organisms was
significantly higher than that of Gram-positive (79.7%
vs 20.3%, p=0.001). There were 24 isolates of Klebsiella
spp (Klebsiella pneumoniae-21, Klebsiella oxytoca-2 and
Klebsiella aerogenes-1) which was the predominant Gram-
negative organism while Staphylococcus aureus was the
only Gram-positive pathogen isolated. The overall
prevalence of MDR organisms was 59.3%. MDR
Klebsiella spp, E. coli and Proteus spp constituted 70.8,
71.4 and 20% of  the pathogens respectively.
Antibiotic resistance profile of pathogens isolated
Table 4 shows the resistance pattern of  the Gram-
negative isolates to the tested antibiotics. Antibiotics
classes tested included Penicillins (Augmentin 20+10µg),
Cephalosporins (Cefuroxime 30µg, Ceftazidime 30µg
and Ceftriaxone 30µg), Aminogly-cosides (Gentamycin
30µg and Amikacin 30µg), Fluoroquinolones






















Klebsiella spp 17 (70.8) 7 (29.2) 24 (44.4)
Escherichia coli 5 (71.4) 2 (28.6) 7 (12.9)
Pseudomonas aeruginosa 3 (60) 2 (40) 5 (9.3)
Hafnia alvei 0 (0) 1 (0) 1 (1.9)
Proteus spp 1 (20) 4 (80) 5 (9.3)
Acinetobacter baumannii 1 (100) 0 (0) 1 (1.9)
Staphylococcus aureus 4 (50) 4 (50) 8 (14.8)
Enterobacter cloacae 1 (33.3) 2 (66.7) 3 (5.5)
Total 32 (59.3) 22 (40.7) 54 (100)
MDR- Multidrug resistant organisms

























































































Klebsiella spp 72.7 100 66.7 92.3 69.2 71.4 0.0 83.3 38.5 16.3
Escherichia coli 80.0 100 83.3 80.0 75.0 75.0 NT 100 0.0 0.0
Enterobacter spp 50.0 100 100 NT 100 100 50 100 0.0 100
Hafnia alvei 100 0.0 0.0 NT 100 NT NT NT NT NT
Acinetobacter baumannii 100 100 0.0 NT 100 NT NT 0.0 NT NT
Proteus spp 25.0 80.0 50.0 0.0 33.3 100 NT 33.3 0.0 0.0
Pseudomonas aeruginosa NT 100 100 66.7 100 0.0 100 50.0 25.0 50.0
Overall resistance to
antibiotic (%)
66.7 92.9 67.7 81.8 68.0 70.0 50.0 71.4 28.6 21.4
Table 4: Antibiotic resistance profile of  isolated organisms
* NT- Antibiotic was not test
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(Ciprofloxacin 5µg, Pefloxacin 5µg and Levofloxacin
5µg) and Carbapenem (Meropenem 10µg). There was
high level of resistance to most of the antibiotics
especially the Cephalosporins. Resistance to Amikacin
and Meropenem was low except among Pseudomonas
and Enterobacter isolates.
DISCUSSION
ICU-acquired infections result in increased cost of
hospitalization among patients who develop these
infections and has been reported to account for close
to half  of  total expenditure of  the hospital stay.7 It is
a predictor of mortality and is associated with high
mortality rate in the range of  10-60%.7,13,25 We found
a prevalence of  31% of  ICU acquired infections. This
is a high rate signifying that one out of every three
patients developed infections during the study period.
This value is much higher than 15% reported by a
study done a few years earlier in the same setting,
implying an increasing rate of infection. That study
however did not include the antibiotic profile of
isolated pathogens.26 Our result is comparable to
findings of other studies where high rates of 26-39%
were recorded in Turkey, Brazil, Argentina and other
environments.6,22,27,28 Our finding is not surprising as
this is a resource-limited setting where it has been
reported that high infection rates may be related to
inadequate funding, limited manpower, suboptimal
application of infection control procedures and non-
availability of  guidelines and policies.9,29,30 As with other
studies, despite the higher proportion of men with
ICU infections and the higher number of infections in
the age group 20-29, we did not find a significant
difference in the incidence of infections when the
gender and age groups were compared.22,31
In general, urinary tract infections, pneumonia and
blood stream infections appear to be the most
common ICU infections.13,27,32 Our study found the
lungs to be the most affected site in the ICU patients.
Similar findings have been reported by Erbay et al and
Meric et al and also corroborated by large multicenter
studies.7,22,27,33 Pneumonia secondary to mechanical
ventilation is one of the most common causes of
nosocomial infections.3 Our study population consisted
of patients on mechanical ventilation and the foreign
device employed in the process could therefore have
predisposed them to infection. Although blood stream
infections are reported to be common in many ICU
infections constituting either the most common or
second most common infection, it was however
noticed to be low in our cohort as it was reported in
less than 15% of those with ICU acquired infections;
and was the infection with the lowest prevalence.6,27,28
We observed that there was no similarity in the
distribution of infections seen in a study carried out in
the northern part of the country where skin and soft
tissue infections were the most common infections.34
One reason for this disparity may be because most of
the patients in that study were admitted on account of
road traffic accidents.
More than half of the infections occurring in the ICU
are noted to be caused by Gram-negative bacteria and
our data was consistent with these findings.22,35,36
Although there is a wide variation in the distribution
of these Gram-negative organisms, Pseudomonas spp
appears to predominate globally.7,27,36 We found a
preponderance of Klebsiella spp, especially Klebsiella
pneumoniae, which accounted for close to half of the
isolated organisms. Klebsiella is a common nosocomial
pathogen whose rates of colonization and therefore
likelihood of infection rises dramatically with
hospitalization.37 Acinetobacter baumannii has emerged as
a cause of nosocomial infection and is increasingly
being reported as a cause of ICU infection especially
in immunocompromised patients.38 It has even been
reported as the most common isolate in some studies
on ICU infections.36,39 In this study however, only one
isolate of Acinetobacter was identified during the period
accounting for about 2% of  infections. Acinetobacter
infection is often reported as outbreaks and non-
occurrence of outbreaks may explain the low
prevalence we found in the study period.14 In spite of
the widespread predominance of Gram-negative
pathogens in ICU infections, a contrasting higher
prevalence of Gram-positive organisms was found
in a local study where over 40% of the pathogens
were Staphylococcus aureus.39 Staphylococcus aureus was the
second most common organism identified, and the
only Gram-positive organism found in this study. Our
result is comparable to findings from most studies on
nosocomial infections where Staphylococcus aureus is
usually the predominant Gram-positive pathogen
recovered in healthcare associated infections.27,39,40
The prevalence of antibiotic resistant organisms in our
study population was high. These multidrug resistant
organisms pose a serious concern in the hospital
environment.14 The emergence of resistant pathogens
in the hospital environment has resulted in part from
extensive and also inappropriate use of antibiotics and
options for treating infections caused by these
organisms are becoming limited.17,41 These resistant
pathogens have emerged in the last two decades as a
major infection control issue.36 The scenario is worse
in the ICU where there is extensive antibiotic use and
such resistance affects the outcome for hospitalized
patients.11,13,41 A study carried out in a similar low middle
income country found that 25% of their isolates were
MDR and the risk for infection with these MDR
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organisms was related to inappropriate antibiotic use,
mechanical ventilation and long ICU stay.42
Pathogens recovered from ICU have been noted to
be more resistant to antibiotics when compared to
isolates from other areas of the hospital.43 A study
comparing developing countries to developed ones
noted a striking higher prevalence of ICU infections
and also of resistant pathogens in developing countries
despite similar device utilization rates.44 According to
our results, there was a very high level of resistance to
antibiotics as virtually most isolated pathogens exhibited
resistance to multiple antibiotics. Only Proteus species
was susceptible to a wide range of  antibiotics. There
is an apparent global trend of increasing MDR Gram
negative bacteria in the ICU when compared to the
gram positive pathogens. These organisms, Escherichia
coli and Klebsiella pneumoniae in particular, have their
resistance genes on plasmids which are easily
transferable allowing strains such as Extended
Spectrum Beta Lactamase (ESBL) producers to spread
rapidly.45
More than 70% of  the Klebsiella spp, the most prevalent
isolate, in our study were multidrug resistant. Although
the frequency of isolation of this organism differs in
various studies, the high prevalence of multidrug
resistance is a common occurrence.36,39,43, It is however
interesting to note that despite the level of resistance
of the Klebsiella isolates, all were susceptible to
levofloxacin. This might be due to the relative
infrequent use of Levofloxacin in this setting, sparing
it of selective pressure compared to the more
commonly used fluoroquinolone- Ciprofloxacin.
Antimicrobial resistance has been noted to be very
common in non-fermenting gram negative bacilli such
as Pseudomonas and Acinetobacter in the ICUs in particular.
A recent report from the United States found a third
of their Pseudomonas isolates were resistant to
fluoroquinolones, 13-19% were resistant to ceftazidime,
resistance to amikacin was 6% and the overall MDR
rate was 10%.14 A contrasting much higher picture of
100%, 100% and 25% resistance to fluoroquinolones,
ceftazidime and amikacin respectively were observed
in Pseudomonas isolates in our study while the MDR
rate was 60%. This indicates a high burden of resistance
which requires urgent intervention. A similar high
burden of MDR Pseudomonas in developing countries
has been reported.44 In comparison to other gram
negative bacilli, a remarkably low prevalence of 20%
MDR Proteus spp was found in this study. A similar
pattern of  antibiogram was observed in a study carried
out elsewhere in the country where the isolates were
generally susceptible to fluoroquinolones, cephalos-
porins, aminoglycosides and carbapenems.34 Proteus spp
is not commonly implicated in ICU infections hence
data on its resistance pattern is scarce. However, a few
studies have demonstrated its potential to exhibit
multidrug resistance.46,47
With the exception of Hafnia alvei and a few Proteus
spp, all isolates were resistant to cefuroxime, and the
pattern was similar for ceftazidime. Only Amikacin
and Meropenem exhibited generally good activity
against these Gram-negative organisms which is similar
to other recent reports by Sader et al.43 Aggressive
efforts however need to be instituted to retain the
relevance of these antibiotics as the level of resistance
of over 20% to both antibiotics is worrisome and
may escalate to high level of resistance as recently
reported by Qadeer et al. 36
CONCLUSION AND RECOMMENDATION
The prevalence of ICU acquired infections is high with
pneumonia predominating. Our study shows a high
prevalence of multidrug resistant bacteria associated
with these infections and may adversely affect patient
outcome. This reiterates the importance of a continuous
collaboration between ICU care specialists, medical
microbiologists and the infection control team in the
care of  these patients.14  Improved health care funding
coupled with better adherence to infection control
procedures are strategies to improve the current
healthcare preventive measures.14,29 A functional
antimicrobial stewardship programme will ensure
optimal use of antimicrobials and limit development
of  resistance. Evaluation of  surveillance data should
also be carried out regularly to monitor the trends and
institute appropriate actions.16
LIMITATIONS OF THE STUDY
The study was limited by small sample size which
resulted from the short duration of data collection. A
larger sample size spanning several years would have
been more robust for more statistical conclusions to
be made.
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